CDKN2A and acute lymphoblastic leukemia: The prognostic impact of CDKN2A/B deletions in pediatric ALL is still controversial (ALLs, 2005; Novara et al., 2009; Sulong et al., 2009; Abdool et al., 2010; Sarhadi et al., 2013).